REG - Oxford Biomedica PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">OXB.L</Origin>

Oxford BioMedicaAnnouncement

25/01/2017 16:06

RNS Number : 0652V
Oxford Biomedica PLC
25 January 2017
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
1
Issuer
Oxford BioMedica PLC
2
Reason for notification
Notification relates to DTR 3.1.2R
3
Name of PDMR
Martin Diggle
4
Connected person
Notification relates to following connected persons:
Vulpes Life Sciences Fund
5
Notification in respect of
Notification in respect of holdings of persons in 4 above
6
Description of shares
Oxford BioMedica PLC ordinary shares of 1p each
7
Name of registered shareholders and number of shares
Vulpes Life Sciences Fund - 549,732,000 shares
Vulpes Testudo Fund - 33,333,333 shares
8
Nature of transaction
Acquisition
9
Number of shares acquired
Vulpes Life Sciences Fund - 200,000 shares
10
Percentage of issued class acquired
Vulpes Life Sciences Fund - 0.01%
11
Shares disposed
N/A
12
Percentage of issued class disposed
N/A
13/14
Price per share of transactions, and date
Vulpes Life Sciences Fund 
200,000 shares @ 0.042 , 24 Jan 2017
15
Total holding following notification and total percentage holding following notification
Vulpes Life Sciences Fund - 549,932,000 shares
17.81%
Vulpes Testudo Fund - 33,333,333 shares
1.08%
16
Date issuer informed
25 Jan 2017



23
Any additional information
None
24
Contact name and telephone number
T. Watts, Chief Financial Officer
Oxford BioMedica
+44 (0)1865 783000

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHGCGDBBGDBGRU